title: The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromes.
abstract: Serum lipid profiles were obtained in 108 patients with myelodysplastic syndrome (MDS) and compared to 28 healthy volunteers. Serum cholesterol and low-density and high-density lipoproteins (LDL and HDL) were found to be significantly lower in MDS patients than in normals (p = 0.0001, 0.0038 and 0.037, respectively). This difference was significant for all MDS categories. Serum cholesterol and HDL were negatively related to biopsy cellularity (p = 0.001 and 0.0001, respectively), and serum triglycerides were negatively related to labeling index (p = 0.0003). No differences were noted in the lipid profiles of MDS patients with normal versus abnormal karyotypes. However, low-risk MDS patients with abnormal karyotypes had significantly lower triglyceride levels compared with the high-risk patients (p = 0.027), as did low-risk patients with normal cytogenetics (p = 0.015). Serum HDL levels were significantly higher for the low-risk group with normal cytogenetics as well (p = 0.003). We conclude that serum cholesterol, LDL, and HDL are significantly reduced in MDS patients, probably indicating excessive intracellular lipid biosynthesis in the expanding clone. These relatively simple measurements could serve as important prognostic markers and reliable indicators of disease activity in individual patients. Prospective studies to determine their utility as independent variables that guide the need for active therapeutic intervention are warranted.
authors.affiliation: Rush Cancer Institute, Rush-Presbyterian St. Luke's Medical Center, Chicago, IL 60612-3515, USA.
authors.forename: K
authors.initials: K
authors.lastname: Allampallam
authors.forename: D
authors.initials: D
authors.lastname: Dutt
authors.forename: C
authors.initials: C
authors.lastname: Nair
authors.forename: V
authors.initials: V
authors.lastname: Shetty
authors.forename: S
authors.initials: S
authors.lastname: Mundle
authors.forename: L
authors.initials: L
authors.lastname: Lisak
authors.forename: C
authors.initials: C
authors.lastname: Andrews
authors.forename: B
authors.initials: B
authors.lastname: Ahmed
authors.forename: L
authors.initials: L
authors.lastname: Mazzone
authors.forename: F
authors.initials: F
authors.lastname: Zorat
authors.forename: R
authors.initials: R
authors.lastname: Borok
authors.forename: M
authors.initials: M
authors.lastname: Muzammil
authors.forename: A
authors.initials: A
authors.lastname: Gundroo
authors.forename: I
authors.initials: I
authors.lastname: Ansaarie
authors.forename: A
authors.initials: A
authors.lastname: Raza
mesh_terms: D000328:Adult; D000368:Aged; D000753:Anemia, Refractory / Q000097:blood; D000754:Anemia, Refractory, with Excess of Blasts / Q000097:blood; D000756:Anemia, Sideroblastic / Q000097:blood; D017209:Apoptosis; D002455:Cell Division; D002784:Cholesterol / Q000097:blood; D002869:Chromosome Aberrations; D003582:Cytogenetics; D005260:Female; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000097:blood; D007958:Leukocyte Count; D008055:Lipids / Q000097:blood* / Q000737:chemistry; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000097:blood* / Q000235:genetics; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D008055:Lipids; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D014280:Triglycerides; D014409:Tumor Necrosis Factor-alpha; D002784:Cholesterol